Akt/Fox M1 signaling pathway-mediated MYBL2 upregulation promotes the progression of human glioma (30) and is a probable candidate gene for molecular targeted therapy and a biomarker for glioma-related radiation therapy. This evidence concerns the gene FOXM1 and glioma.